References
- The CONSENSUS Trial Study Group. The effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316(23): 1429–35
- Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325(5):303–10
- Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 1986; 314(24): 1547–52
- Engelmeier RS, O'Connell JB, Walsh R, et al. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Circulation 1985; 72(3):536–46
- Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in Dilated Cardiomyopathy (MDC) Trial. Lancet 1993; 342(8885): 1441–6
- Packer M, Bristow MR, Cohn JN, et al. The effect of Carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334(21):1349–55
- Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors: RADIANCE study. N Engl J Med 1993; 329(1):1–7
- Konstam MA, Dracup K, Baker DW, et al. Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction. Rockville, MD: Agency for Health Care Policy and Research, US Department of Health and Human Services, 1994 June; Clinical practice guideline No. 11 (AHCPR)94-0612
- The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685–91
- Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991; 325(21):1468–75
- Leier CV, Huss P, Lewis RP, et al. Drug-induced conditioning in congestive heart failure. Circulation 1982; 65(7): 1382–7
- Anderson JL, Bairn DS, Fein SA, et al. Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study. J Am Coll Cardiol 1987; 9(4):711–22
- Feldman AM, Bristow MR, Parmley WW, et al. Effects of ves- narinone on morbidity and mortality in patients with heart failure. N Engl J Med 1993; 329(3):149–55
- Rudy DW, Voelker JR, Greene PK, et al. Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy. Ann Intern Med 1991; 115(5):360–6
- Rich MW, Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333(18): 1190–5